Sivelestat sodium hydrate treatment for refractory Kawasaki disease.
Ryota EbataKumi YasukawaKazue NagaiYuko SaitoKouji HigashiJun HommaNobuyuki TakadaFumie TakechiNaoki SaitoHironobu KobayashiKentaro OkunushiHiromichi HamadaYoichi KohnoHideki HanaokaNaoki ShimojoPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2019)
Additional IVIG combined with SSH as a second-line therapy for KD refractory to initial IVIG therapy was safe and well tolerated and could be a promising option for severe KD. Further investigations are expected to clarify the safety and timing of SSH treatment for KD.
Keyphrases